You searched for Antibody candidate - Page 23 of 69

News and Trends 1 Dec 2016

Spain joins the Antibody-Drug Conjugate Bandwagon to fight Cancer

…antibody-drug conjugate (ADC) candidate, MI130110, against fibrosarcoma and multiple myeloma. Which means the popular ADC field has managed to attract yet another company into what could be a major breakthrough…

December 1, 2016 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 9 Jun 2016

German Biotech launches Phase II in a hot Target for Inflammation

InflaRx has treated the first patient in a new Phase II trial, which is studying the potential of its anti-complement antibody in avoiding immunological complications after complex cardiac surgery –…

June 9, 2016 - 3 minutesmins - By Denise Neves Gameiro

large molecule manufacturing: Lonza woman working in laboratory

Large molecule manufacturing: addressing challenges with strategies for success

…the characteristics of the molecule. This panel of offerings covers a broad range of protein modalities that include antibody-based products, such as bispecific antibodies, Fc-Fusion proteins, and antibody fragments, and…

March 26, 2024 - 8 minutesmins - By Alexander Burik

News and Trends 24 Feb 2025

Over $3 billion in a month: Why is Eli Lilly starting 2025 on a buying spree?

…but this time around, for the chronic respiratory illness idiopathic pulmonary fibrosis (IPF). The candidate MTX-463 is a human IgG1 antibody designed to neutralize WISP1-mediated fibrotic signaling in IPF. The…

February 24, 2025 - 7 minutesmins - By Roohi Mariam Peter

copenhagen biothec genmab symphogen zealand

Best in Biotech 3 May 2016

Here are 12 Biotechs you need to know in Copenhagen – Skål!

…in the Danish capital? As usual, the list is in no particular order. Founded in 1999, Genmab is developing antibody therapies for cancer and is now the biggest European Biotech….

May 3, 2016 - 6 minutesmins - By Denise Neves Gameiro

News and Trends 22 Jun 2020

Swedish Biotech’s Psoriasis Drug Beats Placebo in Phase II

…the market such as Humira and Cosentyx, these antibody drugs aren’t well suited to subcutaneous injections because they can’t penetrate subcutaneous tissue well. Affibody’s psoriasis candidate is a protein drug…

June 22, 2020 - 3 minutesmins - By David Wilson

bicycle therapeutics solid tumors trial 1

News and Trends 14 Feb 2018

Bicycle’s First Peptide-Toxin Conjugate Enters the Clinic for Solid Tumors

…has dosed the first patient in a Phase I/IIa trial with its solid tumors candidate, BT1718. The study will test the drug’s safety and efficacy in around 120 patients with…

February 14, 2018 - 3 minutesmins - By Alex Dale

In Depth 28 Jul 2022

How can vaccines keep up with evolving Covid-19 variants?

…the spike antigen becomes. This makes the key target of the antibody response more subject to mutations,” said Alexandre Le Vert, executive chairman and co-founder of the French vaccine firm…

July 28, 2022 - 7 minutesmins - By Jonathan Smith

News and Trends 7 May 2019

Belgian Biotech Raises €30M Series A to Unlock Undruggable Targets

…led by the VCs BioGeneration Ventures and Wellington Partners, and joined by several other private and public investors. With the money, Confo Therapeutics aims to test its first drug candidate…

May 7, 2019 - 3 minutesmins - By Clara Rodríguez Fernández

News and Trends 27 Nov 2018

Berlin Biotech Raises €24M to Progress Septic Shock Candidate to Clinic

Adrenomed closed a €24M Series D round to fund further development of its antibody drug that treats septic shock by preventing excessive fluid loss and preserving the blood vessel walls….

November 27, 2018 - 3 minutesmins - By Helen Albert

In Depth 21 Nov 2024

Huntington’s disease: a therapeutic field on a bumpy ride

…in 2022 upon demanding more dosage data. Prilenia’s Huntington’s candidate pridopidine accepted for EMA review Meanwhile, Dutch biotech Prilenia Therapeutics’ Huntington’s candidate is en route to approval. Two weeks ago,…

November 21, 2024 - 9 minutesmins - By Roohi Mariam Peter

News and Trends 11 Oct 2022

License granted to EnteroBiotix for manufacture of microbiome product candidates

Microbiome therapeutics company, EnteroBiotix Limited has been granted a manufacturer’s license for a GMP manufacturing facility for Investigational Medicinal Products (IMP) to make microbiome product candidates for clinical trials. It…

October 11, 2022 - 2 minutesmins - By Liza Laws

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Antibody candidate

Spain joins the Antibody-Drug Conjugate Bandwagon to fight Cancer

German Biotech launches Phase II in a hot Target for Inflammation

Large molecule manufacturing: addressing challenges with strategies for success

Over $3 billion in a month: Why is Eli Lilly starting 2025 on a buying spree?

Here are 12 Biotechs you need to know in Copenhagen – Skål!

Swedish Biotech’s Psoriasis Drug Beats Placebo in Phase II

Bicycle’s First Peptide-Toxin Conjugate Enters the Clinic for Solid Tumors

How can vaccines keep up with evolving Covid-19 variants?

Belgian Biotech Raises €30M Series A to Unlock Undruggable Targets

Berlin Biotech Raises €24M to Progress Septic Shock Candidate to Clinic

Huntington’s disease: a therapeutic field on a bumpy ride

License granted to EnteroBiotix for manufacture of microbiome product candidates

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!